A prospective, first-in-human use of the NeVa mechanical thrombectomy device for patients with acute coronary syndromes.

ABSTRACT:

Background

There is no established technique for managing large thrombus burden (LTB) in patients with acute coronary syndrome (ACS).

Aims

The aim of this study was to assess the safety and efficacy of the NeVa (Vesalio) mechanical thrombectomy device (MTD) in ACS patients with LTB.

Methods

Consecutive patients with ACS and LTB were treated with the NeVa MTD as the primary vessel recanalisation and thrombus removal modality, followed by conventional intervention. We further developed a bench model and applied to a subset of patients, a vacuum-assisted aspiration technique, exploiting 6 Fr-compatible conventional guiding catheter extensions, as an adjudicative manoeuvre to the use of stent-based MTD. A core laboratory reviewed the angiographic images for procedural com

SUBMITTER: Spirito A 

PROVIDER: S-EPMC9912965 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature